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Abstract Elevated levels of cardiac mitochondrial
uncoupling protein 3 (UCP3) and decreased cardiac
efficiency (hydraulic power/oxygen consumption) with
abnormal cardiac function occur in obese, diabetic mice.
To determine whether cardiac mitochondrial uncoupling
occurs in non-genetic obesity, we fed rats a high fat diet
(55% kcal from fat) or standard laboratory chow (7% kcal
from fat) for 3 weeks, after which we measured cardiac
function in vivo using cine MRI, efficiency in isolated
working hearts and respiration rates and ADP/O ratios in
isolated interfibrillar mitochondria; also, measured were
medium chain acyl-CoA dehydrogenase (MCAD) and cit-
rate synthase activities plus uncoupling protein 3 (UCP3),
mitochondrial thioesterase 1 (MTE-1), adenine nucleotide
translocase (ANT) and ATP synthase protein levels. We
found that in vivo cardiac function was the same for all
rats, yet oxygen consumption was 19% higher in high fat-
fed rat hearts, therefore, efficiency was 21% lower than in
controls. We found that mitochondrial fatty acid oxidation
rates were 25% higher, and MCAD activity was 23%
higher, in hearts from rats fed the high fat diet when
compared with controls. Mitochondria from high fat-fed rat
hearts had lower ADP/O ratios than controls, indicating
increased respiratory uncoupling, which was ameliorated
by GDP, a UCP3 inhibitor. Mitochondrial UCP3 and MTE-
1 levels were both increased by 20% in high fat-fed rat
hearts when compared with controls, with no significant
change in ATP synthase or ANT levels, or citrate synthase
activity. We conclude that increased cardiac oxygen util-
isation, and thereby decreased cardiac efficiency, occurs in
non-genetic obesity, which is associated with increased
mitochondrial uncoupling due to elevated UCP3 and
MTE-1 levels.
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PPAR Peroxisome proliferator activated receptor
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MTE-1 Mitochondrial thioesterase-1
ANT Adenine nucleotide translocase
MCAD Medium chain acyl-CoA dehydrogenase
ACR Acceptor control ratio
gww Gram wet weight
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Introduction
The metabolic syndrome, defined as central obesity accom-
panied by any two of hypertriglyceridaemia, decreased
HDL cholesterol, hyperglycaemia and hypertension [1], is
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increasingly common in Western populations and is asso-
ciated with increased risk of type 2 diabetes and cardiovas-
cular disease [15]. Humans with type 2 diabetes have
impaired cardiac high energy phosphate metabolism, which
precedes changes in contractile function [39] and may arise
from abnormal mitochondrial respiration impairing ATP
synthesis. Isolated, perfused hearts from mice with type 2
diabetes have decreased efficiency when compared with
wild-type mouse hearts [4, 23], possibly caused by increased
mitochondrial uncoupling protein 3 (UCP3) levels [4]. UCPs
allow protons to re-enter the mitochondrial matrix inde-
pendent of ATP synthase (Fig. 1), a process inhibited by
nucleoside di- and triphosphates, including GDP [53]. Car-
diac UCP3 mRNA [50] and protein [29] levels increase with
high plasma free-fatty acid (FFA) concentrations, acting via
peroxisome proliferator-activated receptor a (PPARa) [31].
Levels of UCP3 in human heart have been found to correlate
positively with plasma FFA concentrations [29] and lower-
ing plasma FFAs decreased UCP3 levels and normalised
efficiency in the diabetic mouse heart [23]. High plasma
FFAs also increase mitochondrial uncoupling, because fatty
acids are intrinsic UCP activators [36]. Activation of PPARa,
via increased plasma FFAs, can also upregulate mitochon-
drial thioesterase-1 (MTE-1), which is believed to work in
conjunction with UCP3 to increase mitochondrial uncou-
pling and/or fatty acid oxidation [45]. Therefore, high
plasma FFAs are associated with increased mitochondrial
UCP3 levels and uncoupling.
Studies that associate high cardiac UCP levels with
elevated circulating FFA concentrations [4, 23, 29] have
used the obese ob/ob and diabetic db/db mouse models,
which have mutations in the leptin and leptin receptor
genes, respectively [27, 35]. It is unknown whether cardiac
UCP3 levels and mitochondrial uncoupling are elevated in
milder, pre-diabetic forms of obesity, and thereby form an
early stage of disease progression. Consequently, we fed
rats a high fat diet (55% kcal from saturated fat) or normal
laboratory chow (7% kcal from saturated fat) to induce
obesity, but not overt insulin resistance. We measured
cardiac function in vivo using magnetic resonance imaging
(MRI) and function and efficiency (hydraulic power/O2
consumption) in isolated, perfused working hearts from
these rats. We then isolated cardiac interfibrillar mito-
chondria and measured mitochondrial respiration rates
and ADP/O ratios with glutamate, palmitoyl-carnitine or
pyruvate as substrates (Fig. 1). We also measured mito-
chondrial UCP3, MTE-1, adenine nucleotide translocase
(ANT) and F0F1 ATP synthase protein levels, as well as
activities of the mitochondrial oxidation enzymes, medium
chain acyl-CoA dehydrogenase (MCAD) and citrate syn-
thase. We hypothesised that diet-induced high plasma FFA
concentrations would increase cardiac mitochondrial UCP3
protein levels, thereby increasing mitochondrial uncou-
pling and reducing cardiac efficiency.
Materials and methods
Animals
Male Wistar rats (*300 g) (n = 36) were obtained from a
commercial breeder (Harlan, Oxfordshire, UK) and housed
in groups of three under controlled conditions for tempera-
ture, humidity and light, in accordance with the UK Home
Office and US NIH guidelines, with water available ad libi-
tum. All rats were initially fed standard laboratory chow
ad libitum (Rat and Mouse No. 1 Maintenance, Special Diet
Services, Witham, Essex, UK), which had an Atwater Fuel
Energy (AFE) of 3.3 kcal/g, comprising 7.5% from oil,
17.5% from protein and 75% from carbohydrate. Three days
after arriving, half the rats were switched from standard
chow to a custom-produced high fat diet (Special Diet
Services, Witham, Essex, UK), which had an AFE of
5.1 kcal/g, comprising 55% from oil, 29% from protein and
16% from carbohydrate. The remaining rats continued on
Fig. 1 The metabolic fates of mitochondrial energy substrates.
1 Glutamate enters the mitochondrion via the aspartate/glutamate
carrier and is oxidised to a-ketoglutarate by glutamate dehydrogenase.
2 Palmitoyl carnitine is imported by the carnitine palmitoyl transfer-
ase (CPT) shuttle, and oxidised by b-oxidation, to reduce FAD? and
NAD? to FADH2 and NADH, respectively, producing acetyl CoA.
3 Pyruvate enters via the pyruvate carrier and is oxidised by pyruvate
dehydrogenase (PDH) reducing NAD? and producing acetyl CoA.
Acetyl CoA enters the tricarboxylic acid (TCA) cycle, producing
NADH and FADH2, which are oxidised by complexes I and II,
respectively, of the electron transport chain, which consists of
complexes I–IV. Electrons are transferred through the chain to the
final acceptor, O2. The free energy from electron transfer is used to
pump H? out and generate an electrochemical gradient, DlH?, across
the inner mitochondrial membrane, which is the driving force for ATP
synthesis via ATP synthase. Alternatively, H? can re-enter the
mitochondria independent of ATP synthesis, via the uncoupling
proteins (UCPs), resulting in the dissipation of energy
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chow. Rats were fed these diets for up to 3 weeks ad libitum,
with food intake and body weights measured each day.
A 3-week duration of high fat feeding was chosen as that
sufficient to significantly elevate plasma FFA as compared
to control animals.
Cardiac magnetic resonance imaging
After 3 weeks of feeding, anaesthesia was induced in one
group of control (n = 5) and high fat-fed (n = 5) rats using
4% isoflurane in 100% oxygen. Rats were placed in a
purpose built cradle for subsequent vertical positioning in
the magnet bore [48]. Maintenance anaesthesia was
1.5–2% isoflurane at 1 l min-1 oxygen flow. Heart elec-
trical activity and respiration were monitored, using an in-
house electrocardiography and respiratory gating device,
via subcutaneous needle electrodes inserted into the fore
limbs, and a motion loop on the abdomen, respectively.
As described previously [48], magnetic resonance
imaging was carried out on an 11.7 T (500 MHz) vertical
bore (123-mm internal diameter) system (Magnex Scien-
tific, Oxon, UK), using a Bruker Avance console (Bruker
Medical, Ettlingen, Germany) with a linear transmit and
receive, 500 MHz birdcage coil with an inner diameter of
60 mm (constructed in-house).
Long- and short-axis scout images of the heart, using a
cardiac- and respiration-gated segmented fast low angle
shot sequence, were used to position 7–8 contiguous, short-
axis slices (slice thickness 1.5 mm) covering the entire
heart. The sequence was electrocardiogram and respiration
gated and between 20 and 30 frames per heart cycle were
acquired, depending on the heart rate. The field of view
was 5.12 9 5.12 cm with a matrix size of 256, TE/
TR = 1.43/4.6 ms. One phase-encoding step was acquired
per heart beat and four or eight phase encoded steps
acquired per respiration cycle, resulting in a total experi-
mental time of approximately 1 h.
Image reconstruction was performed using purpose-
written software in Matlab (Mathworks, Natick, Maryland,
USA). Raw data were isotropically zero-filled by a factor of
two and filtered (modified third-order Butterworth filter)
before Fourier transformation, resulting in an in-plane voxel
size of 100 9 100 lM. Image data were exported into
Scion Image (Scion Corporation, Frederick, Maryland,
USA). End-diastolic and end-systolic frames were selected
according to maximal and minimal ventricular volumes. In
both frames, the epicardial border and left ventricular cavity
were outlined and left ventricular mass was obtained by
multiplying the volume by the specific gravity of myocar-
dial tissue (1.05 g/cm3). Based on the end-systolic volumes
(ESV) and end-diastolic volumes (EDV), all parameters
characterising cardiac function, such as stroke volume
(SV = EDV - ESV), ejection fraction (EF = SV/EDV)
and cardiac output (CO = SV 9 heart rate) were
calculated.
Isolated working heart perfusion
Another group of control (n = 7) and high fat-fed (n = 7)
rats were anaesthetised with a 0.8 ml i.p. injection of
60 mg ml-1 sodium pentobarbitone (Sagatal, Rhoˆne Me`r-
ieux, Dublin, Ireland). Following the cessation of periph-
eral nervous function, hearts were excised and arrested
using ice-cold modified Krebs–Henseleit buffer (118 mM
NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 1.75 mM CaCl2,
0.5 mM Na2EDTA, 25 mM NaHCO3, 1.2 KH2PO4).
Hearts were weighed before perfusion, and then perfused in
Langendorff mode for 10 min with modified Krebs–
Henseleit buffer containing 11 mM glucose, 0.2 mM
pyruvate and 0.5 mM lactate as substrates. After left atrial
cannulation, hearts were switched to the working mode for
20 min with 200 ml of recirculating buffer. Preload was
15 mmHg and afterload was 80 mmHg. Hearts were then
perfused with buffer containing 0.2 mM palmitate pre-
bound to essentially fatty acid free 1.5% wt/vol bovine
serum albumin (BSA) for 20 min. This was followed by
20 min perfusion with buffer containing 1 mM palmitate
pre-bound to 1.5% BSA. In four experiments, hearts were
perfused with buffer containing 1 mM palmitate, then
0.2 mM palmitate to ensure that the order of buffer change
did not affect the results. Aortic and coronary flows were
measured every 10 min and, using online measurement of
aortic developed pressure, cardiac power was calculated
[3]. Atrial venous oxygen concentration differences were
determined using online chemifluorescence methods,
which simultaneously monitored temperature-compensated
oxygen partial pressure in the atrial inflow line, and from
the pulmonary trunk. The oxygen content of buffer flowing
in the left atrium was maintained above 550 mmHg
throughout all experiments. Heart temperature was main-
tained at 37.4 ± 0.2C. Myocardial oxygen consumption
was calculated using the arterio-venous differences and
coronary flows. Cardiac efficiency was calculated from
cardiac power and myocardial oxygen consumption [3].
Hearts were snap-frozen in liquid nitrogen for subsequent
biochemical analyses.
Isolation of mitochondria
A further group of control (n = 6) and high fat-fed (n = 6)
rats were anaesthetised as described in the perfusion study.
After the cessation of peripheral nervous function, hearts
were quickly excised and arrested in ice-cold mitochon-
drial isolation solution (100 mM KCl, 50 mM MOPS,
1 mM EGTA, 5 mM MgSO4.7H2O, 1 mM ATP, pH 7.4).
A sample of whole left ventricle (*80 mg) was washed in
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mitochondrial isolation solution, frozen using pre-cooled
Wollenberger clamps under liquid nitrogen and stored at
-80C for later analysis of enzyme activity. The remaining
left ventricular tissue was used for mitochondrial isolation.
Epididymal fat pads were removed from the carcass and
weighed, as an indicator of whole body adiposity [52].
Interfibrillar mitochondria were isolated from rat hearts
as previously described [33] except that a modified Chap-
pell–Perry buffer (containing 100 mM KCl, 50 mM
MOPS, 1 mM EGTA, 5 mM MgSO4.7H2O, and 1 mM
ATP, pH 7.4 at 4C) was used. The final mitochondrial
suspension was immediately used for measurement of
mitochondrial respiratory parameters, and the remaining
preparation later stored at -80C for production of protein
lysates for immunoblotting.
Measurement of mitochondrial respiratory parameters
Respiratory rates of rat heart mitochondria were measured
using a Clark-type oxygen electrode (Strathkelvin Instru-
ments Ltd, Glasgow, UK). Respiration rates were recorded
and quantified using 782 Oxygen System v3.0 software
(Strathkelvin Instruments). Oxygen concentrations were
measured in 0.5 ml respiration medium (100 mM KCl,
50 mM MOPS, 1.0 mM KH2PO4, 1.0 mg/ml defatted
BSA, pH 7.4) in two respiration chambers maintained at
30C containing magnetic stirrers [25]. The chambers were
treated identically throughout the experiment, except that
one contained 1 lmol GDP (dissolved in 10 ll of H2O, pH
7.4), added to the respiratory medium at the start of the
experiment (i.e. before mitochondria were added) and
allowed to mix. GDP is an inhibitor of the mitochondrial
uncoupling proteins [53], such that differences between the
two chambers indicate the influence of UCP3 on oxygen
utilisation. Oxygen concentrations were first recorded in
the absence of mitochondria, and after the addition of
approximately 0.5 mg mitochondrial protein, assayed using
a protein assay kit (Pierce, Rockford IL, USA). Glutamate
(20 mM), malate (5 mM) plus pyruvate (0.5 mM) or
malate (5 mM) plus palmitoyl carnitine (0.04 mM), were
added as substrates, before State III respiration was
stimulated by the addition of 100 nmol of ADP. State IV
respiration, which occurred when all the ADP added to the
respiration medium had been phosphorylated, was subse-
quently measured. State III and state IV measurements
were repeated after addition of a further 100 nmol of ADP.
Acceptor control ratios (ACRs) were calculated as an
indication of mitochondrial integrity by dividing state III
respiration rates by state IV respiration rates. ADP/O ratios
(the ratios of molecules of ADP phosphorylated for each
oxygen atom consumed) were calculated as described by
Estabrook [16]. ADP/O ratios are independent of the rates
of oxygen consumption and give a more sensitive and
precise measure of mitochondrial respiratory coupling than
can be inferred from respiration rates alone.
Enzyme analysis
Whole snap-frozen heart tissue was crushed under liquid
nitrogen and activities of the mitochondrial b-oxidation
enzyme MCAD and citrate synthase, a measure of mito-
chondrial content, were measured using methods described
previously [20].
Immunoblotting
Levels of cardiac UCP3 protein were measured in mito-
chondrial preparations by immunoblotting, as described
previously [30], using a polyclonal rabbit anti-UCP3
antibody (Alpha Diagnostic International, San Antonio,
TX) at a concentration of 1:1,000 in 5% milk TBS–
Tween. MTE-1 protein levels were measured in mito-
chondrial preparations as described previously [26], using
a polyclonal rabbit anti-MTE-1 antibody (gift of Dr Stefan
Alexson, Karolinska Institutet, Stockholm, Sweden) at a
concentration of 1:2,000 in 5% milk TBS–Tween. Levels
of ANT protein were determined using a polyclonal goat
anti-ANT antibody (Santa Cruz Biotechnology, CA, USA)
as described previously [29]. Levels of F0F1 ATP synthase
a-subunit protein were determined using a polyclonal
mouse anti-a subunit F0F1 ATP synthase antibody (Mito-
sciences Inc, Eugene, USA) at a concentration of 1:2,000
in 5% milk TBS–Tween. Total cellular GLUT 4 protein
content was determined using a monoclonal anti-COOH-
terminal GLUT4 antibody (kind gift, G.D. Holman, Bath),
as described previously [34]. The secondary antibody
used, in all cases, was the appropriate horseradish peroxi-
dase conjugate polyclonal antibody (Autogen Bioclear,
Wiltshire, UK) at a concentration of 1:3,500 in 5%
milk TBS–Tween. Even protein loading and transfer were
confirmed by Ponceau staining, and protein levels were
related to internal standards to ensure homogeneity
between samples and gels. Bands were quantified using
UN-SCAN-IT gel software (Silk Scientific, USA), and all
samples were run in duplicate on separate gels to confirm
results.
To measure oxidative modification of mitochondrial
proteins, protein carbonylation was measured using
an OxyBlot kit (Millipore, MA, USA). In brief, carbonyl
groups were derivatised to 2,4-dinitrophenylhydrazone
(DNP) by 2,4-dinitrophenylhydrazine, and proteins were
then separated on a gel, using western blotting techniques
described above. Blots were incubated with a DNP-specific
antibody contained in the kit, and the sum of the separated
protein bands was quantified as total protein carbonylation
in the sample.
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Blood plasma analyses
At the point of heart excision, blood was taken from the
chest cavity, rapidly centrifuged at 1,0009g at 4C, and the
plasma frozen at -80C for biochemical analysis. Lipo-
protein lipase inhibitor (2%) was added to an aliquot of
plasma for non-esterified FFA analysis. Plasma levels of
glucose, triglycerides, total cholesterol, HDL cholesterol
and LDL cholesterol were measured using an ABX Pentra
Clinical Chemistry bench-top analyser (Horiba ABX,
Montpellier, France). Plasma levels of FFAs were mea-
sured using an NEFA assay kit (Wako Chemicals GmbH,
Neuss, Germany).
Statistics
Grouped data (mean ± SEM) were analysed using two-
way ANOVAs. Data involving time or a change in perfu-
sion substrate were analysed using a mixed design
ANOVA with repeated measures, using Bonferroni’s cor-
rection where appropriate. Correlations were tested for
significance using Pearson’s product moment statistics.
The results were considered significantly different at
p \ 0.05.
Results
Morphological parameters and in vivo cardiac function
All rats consumed a similar weight of food each day
(Table 1); however, the high fat diet had a greater caloric
density than the standard laboratory chow, so the high
fat-fed rats consumed 86% more calories than chow-fed
controls (p \ 0.0001). The greater calorie consumption
resulted in the high fat-fed rats having 12% greater body
weights than controls after 3 weeks (p \ 0.05). Corre-
spondingly, the hearts of the high fat-fed rats were 10%
heavier than those from controls (p \ 0.05), and in pro-
portion to the increase in body weight, as all rats had the
same heart/body weight ratios. High fat-fed rats had greater
adiposity, as suggested by 67% larger epididymal fat pads
(p \ 0.01). In vivo ejection fractions, stroke volumes, heart
rates and cardiac outputs were the same for all rats (Table 1).
Fasting blood plasma metabolites
All rats had similar fasting plasma levels of glucose and
triglycerides (Table 1). Fasting plasma levels of free-fatty
acids were elevated by 52% to 0.38 mM in the high fat-fed
rats when compared with 0.25 mM in the control rats
(p \ 0.05). Total blood cholesterol levels were 25% higher
in the high fat-fed rats at 2 mM when compared with
1.6 mM in controls (p \ 0.05), with an increased LDL
cholesterol fraction of 0.19 mM when compared with
0.04 mM in controls (p \ 0.0001), and no difference in the
HDL cholesterol fraction.
Isolated working heart
Consistent with in vivo measurement of cardiac function,
aortic flows were the same for all rat hearts at all palmitate
concentrations (Fig. 2). Coronary flows were 15% greater
in high fat-fed rat hearts under all perfusion conditions
(p \ 0.04), but cardiac outputs were the same for all hearts.
Therefore, high fat feeding had no significant effect on
cardiac function, whether measured in vivo (Table 1) or in
the isolated heart (Fig. 2).
Oxygen consumption in chow-fed rat hearts was signi-
ficantly increased on perfusion with 1 mM palmitate, when
compared with perfusion with no palmitate, or with 0.2 mM
palmitate (Fig. 3, p \ 0.02). Overall, oxygen consumption
in high fat-fed rat hearts was 19% higher than chow-fed rat
Table 1 Daily dietary intake, morphological parameters, cardiac







Food intake (g/day) 17.5 ± 1.7 20 ± 0.8
Calorie intake (kcal/day) 58 ± 6 102 ± 4****
Morphological data
Body weight (g) 415 ± 13 466 ± 17*
Heart weight (g) 0.98 ± 0.03 1.08 ± 0.03*
HW/BW 9 1,000 2.38 ± 0.05 2.34 ± 0.06
Epididymal fat weight (g) 11.4 ± 0.9 19.0 ± 1.8**
In vivo cardiac MRI
Left ventricle mass (g) 0.45 ± 0.03 0.49 ± 0.04
Septal wall thickness (mm) 1.70 ± 0.06 1.75 ± 0.1
Ejection fraction (%) 77 ± 1 74 ± 1
End-diastolic volume 306 ± 23 307 ± 20
End-systolic volume 70 ± 6 79 ± 7
Stroke volume (ll) 236 ± 17 228 ± 16
Heart rate (bpm) 442 ± 9 473 ± 27
Cardiac output (ml.min-1) 104 ± 8 108 ± 10
Fasting plasma metabolites
Glucose (mM) 9.5 ± 0.7 11.2 ± 1.1
Triglycerides (mM) 1.6 ± 0.1 1.9 ± 0.2
Free-fatty acids (mM) 0.25 ± 0.03 0.38 ± 0.04*
Total cholesterol (mM) 1.6 ± 0.1 2.0 ± 0.1*
LDL cholesterol (mM) 0.04 ± 0.01 0.19 ± 0.02****
HDL cholesterol (mM) 0.65 ± 0.04 0.88 ± 0.11
* p \ 0.05, ** p \ 0.01, **** p \ 0.0001 versus controls
(HW/BW = heart weight/body weight)
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hearts (p \ 0.01), but was independent of palmitate con-
centration. Consistent with measurements of in vivo func-
tion, cardiac power in high fat-fed rat hearts (8.8 ±
0.7 mW) was the same as chow-fed rat hearts (9.4 ±
0.6 mW) under all perfusion conditions. Cardiac efficiency
was higher in chow-fed rat hearts when perfused without
palmitate than with either 0.2 mM (p \ 0.01) or 1.0 mM
palmitate (p \ 0.02). Cardiac efficiency was on average
21% lower in high fat-fed rat hearts than in chow-fed rat
hearts (Fig. 3), as a consequence of the increased oxygen
consumption. High fat-fed rat hearts had 43% lower effi-
ciency as compared to chow-fed rat hearts when perfused
without palmitate (p \ 0.01), and 28% lower efficiency
when perfused with 1.0 mM palmitate (p \ 0.05).
Respiration in isolated mitochondria
State 3 respiration rates were higher in isolated cardiac
mitochondria from high fat-fed rats than chow-fed rats
(p \ 0.05) in the presence of palmitoyl carnitine and
malate (Fig. 4), but were unchanged with pyruvate and
malate or glutamate as substrates. The addition of the
UCP3 inhibitor, GDP, did not significantly change state 3
respiration rates. With all substrates, state 4 respiration
rates (Fig. 4) were not significantly different in cardiac
mitochondria from high fat-fed when compared with chow-
fed animals, and were unchanged with the addition of
GDP. ADP/O ratios were lower in cardiac mitochondria
from high fat-fed rats as compared to those from chow-fed
animals, irrespective of substrate (p \ 0.01). The addition
of GDP did not alter ADP/O ratios of mitochondria from
chow-fed rat hearts (Fig. 4), but normalised the ADP/O
ratio in high fat-fed rat heart mitochondria (p \ 0.01) with
all substrates.
MCAD and citrate synthase activity and GLUT 4
protein expression
Cardiac MCAD activity (Fig. 5) was 23% higher in high
fat-fed rat hearts (p \ 0.05). Citrate synthase activity was
the same for all hearts (119 ± 4 lmol gww-1 min-1
after chow feeding and 124 ± 6 lmol gww-1 min-1
after high fat feeding), indicating higher cardiac b-oxi-
dation in high fat-fed animals with unchanged cardiac
mitochondrial content. MCAD activity correlated posi-
tively (p \ 0.001) with oxygen consumption in hearts
perfused with 0.2 mM palmitate (Fig. 5, p \ 0.001).
Total cardiac protein levels of the insulin-sensitive glu-
cose transporter, GLUT 4, were unchanged with high fat
feeding (1.0 ± 0.06 after chow feeding, 0.93 ± 0.05




























Fig. 2 Isolated working heart aortic flows, coronary flows and
cardiac outputs (left to right) following 3 weeks of high fat feeding.
Hearts were perfused with three buffers, all of which contained
11 mM glucose, 0.2 mM pyruvate and 0.5 mM lactate as substrates
(clear bars), and the addition of 0.2 mM palmitate (shaded bars), or
1.0 mM palmitate (hatched bars). *p \ 0.05 versus chow fed
Fig. 3 Oxygen consumption (left), cardiac power (middle) and
cardiac efficiency (right) in isolated rat hearts following high fat
feeding. Hearts were perfused with three buffers, all of which
contained 11 mM glucose, 0.2 mM pyruvate and 0.5 mM lactate as
substrates (clear bars), and the addition of 0.2 mM palmitate (shaded
bars), or 1.0 mM palmitate (hatched bars). *p \ 0.05 versus chow-
fed rat hearts perfused without palmitate, p \ 0.05 versus chow-fed
rat hearts perfused with 0.2 mM palmitate
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Mitochondrial protein expression and modification
UCP 3 and MTE-1 protein levels (Fig. 6) were both
increased by 20% in high fat-fed rat hearts (p \ 0.05).
Cardiac ANT and F0F1 ATP synthase protein levels did not
differ with high fat feeding (Fig. 6), supporting the finding
that mitochondrial content had not changed with the high
fat diet. Levels of protein carbonylation were the same in
all cardiac mitochondria.
Discussion
In this study, we investigated cardiac function, efficiency
and mitochondrial respiration in a rat model of diet-
induced obesity in the absence of overt diabetes. A high fat
diet increased body and epididymal fat pad weights, sig-
nifying greater body adiposity. Fasting plasma FFA levels
were 52% higher in the high fat-fed animals, with
increased total and LDL cholesterol. The high fat-fed rats
were neither, however, hyperglycaemic in the fasting state,
nor was cardiac GLUT 4 content decreased suggesting that
cardiac glucose metabolism was normal in this short-term
high fat feeding model. We found that isolated, perfused
hearts from high fat-fed rats had decreased efficiency. The
decreased cardiac efficiency following high fat feeding was
solely due to increased oxygen consumption, and we sug-
gest that this was caused by increased fatty acid oxidation
and mitochondrial uncoupling.
Cardiac insulin resistance
We set out in this study to examine cardiac metabolism in a
pre-diabetic model of early dietary-induced obesity, so
there is a possibility that animals were insulin resistant
after 3 weeks of high fat feeding. 4 weeks of feeding a
34% fat diet elevated plasma insulin [17], and 6–8 weeks
of a 60% fat diet produced systemic glucose intolerance
[12, 42]. However, cardiac insulin sensitivity was normal
after 8 weeks of feeding a 60% fat diet, a diet similar to
that in the present study [12]. The heart appears to maintain
a normal insulin response, despite systemic glucose intol-
erance, for a protracted period. For example, the obese
Fig. 4 State 3 respiration rates and ADP/O ratios in rat left
ventricular mitochondria with palmitoyl-carnitine plus malate
(upper), pyruvate plus malate (middle) or glutamate (lower) as
substrates. In addition to the control condition (clear bars),
mitochondria were incubated with the UCP3 inhibitor GDP (shaded
bars). *p \ 0.05 versus chow fed, p \ 0.05 versus high fat-fed
without GDP
Fig. 5 Cardiac medium-chain
acyl-CoA dehydrogenase
(MCAD) activity (left) in chow-
fed (clear bars) and high fat-fed
rats (shaded bars) *p \ 0.05
versus chow fed. Correlation
between cardiac MCAD activity
and oxygen consumption (right)
in isolated perfused working
heart from chow (open symbols)
and high fat-fed rats (closed
symbols)
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Zucker rat had not developed cardiac insulin resistance by
6 months of age, and only had mild cardiac insulin resis-
tance at 12 months [44]. Therefore, short-term high fat
feeding has only a low likelihood of inducing cardiac
insulin resistance.
Cardiac function and efficiency
Mechanical factors may have contributed to increased car-
diac oxygen consumption in our rat hearts. Increased
myocardial oxygen consumption has been closely linked to
increased left ventricular wall stress [24, 46], however in
vivo MRI measurements of cardiac function and morpho-
logy showed no abnormalities in end-diastolic volume or
wall thickness in our high fat-fed rat hearts. In another study
[43], high fat feeding increased systolic blood pressure
by *40%, which would increase wall stress, but afterload
and hydraulic resistance were constant in our isolated
working heart preparation, so the effects of blood pressure
were not relevant. These results indicated to us that the
increase in oxygen consumption was due to changes in
cardiac metabolism, rather than mechanical factors. High
fat-fed rats had normal cardiac function when measured in
vivo or when hearts were perfused in working mode, and
thus it seems that ATP synthesis was maintained. However,
oxygen consumption was increased, with the result that
cardiac efficiency was decreased in high fat-fed rat hearts.
Fatty acid oxidation
We found that high fat-fed rat hearts had increased mito-
chondrial fatty acid oxidation when compared with control
rat hearts. Mitochondria from high fat-fed rat hearts had
increased state 3 respiration only in the presence of pal-
mitoyl-carnitine, whereas respiration was normal with
pyruvate or glutamate. It is likely, therefore, that the
increased respiration rate was associated with the upregu-
lation of enzymes of fat metabolism, such as MCAD
(Fig. 1), which increases in heart following PPARa acti-
vation [19]. MCAD activity was elevated by 23% in high
fat-fed rat hearts, similar to the increase in mitochondrial
fatty acid oxidation, but citrate synthase activity and pro-
tein levels of F0F1 ATP synthase and ANT were unaltered,
therefore an increase in the number of mitochondria could
not account for these differences.
Our finding of increased fatty acid oxidation and MCAD
activity is consistent with long-term high fat feeding
studies [32, 37]. Increased fatty acid oxidation has been
reported in isolated, perfused working rat hearts after
4 weeks of feeding a 60% saturated fat diet, but this was
not associated with decreased cardiac efficiency [51]. Fatty
acid oxidation is unaltered in rats bred for low aerobic
capacity with moderate obesity [41]. In the present study, a
switch in substrate preference away from more oxygen
efficient glucose oxidation, towards fatty acid oxidation
with high fat feeding [5] may have contributed to an
increase in oxygen consumption and decrease in cardiac
efficiency. This effect would be relatively minor, as the
maximum difference in oxygen consumption between
glucose oxidation alone to palmitate oxidation alone is
10–12% [5, 49]. Therefore, increased fatty acid oxidation
would have played a minor role in decreasing cardiac
efficiency with high fat feeding.
High FFAs increased oxygen consumption by up to 40%
in either unloaded or arrested isolated hearts on perfusion
with[1 mM fatty acids [2, 11], and in vivo infusion of 10%
intra-lipid increased oxygen consumption by 26% [28]. In
our study, there was a 20% increase in oxygen consumption
on perfusion with 1 mM fatty acids, and in proportion to the
exogenous fatty acid supply (Fig. 3). The mechanisms
Fig. 6 Expression of mitochondrial inner membrane proteins, UCP3, MTE-1, ANT, FoF1ATP synthase and protein carbonylation (left to right)
in chow-fed (clear bars) and high fat-fed rats (shaded bars) *p \ 0.05 versus chow fed
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responsible for such increases in oxygen consumption in the
normal heart remain unclear, but may be related to direct
action of FFAs on mitochondrial uncoupling [36]. We
found that mitochondrial ADP/O ratios from chow-fed rat
hearts were not affected by GDP, indicating that uncoupling
proteins were not responsible for the increased oxygen
consumption in hearts from chow-fed animals. However,
this does not discount the possibility that direct action of
FFAs cause uncoupling [36] in the absence of changes in
mitochondrial proteins. In contrast to chow-fed rat hearts,
high fat-fed rat hearts had significantly elevated oxygen
consumption even when no exogenous FFA was present,
with reduced cardiac efficiency, which cannot be explained
by the mechanisms described above [2, 36, 38]. This,
therefore, points to abnormalities in oxidative metabolism
downstream of substrate supply (Fig. 1).
Mitochondrial respiration and UCP protein expression
The finding that oxygen consumption in the high fat-fed
isolated heart was increased may be explained by differ-
ences in mitochondrial metabolism. Evidence from both
mitochondrial respiration and protein expression indicate
that mitochondria of high fat-fed hearts were more
uncoupled than chow-fed hearts. In earlier work, we found
that decreased efficiency in the hyperthyroid or chronically
infarcted rat heart was associated with increased mito-
chondrial UCP3 protein levels and increased uncoupling
[3, 30]. In high fat-fed rats, increased UCP3 levels were
associated with decreased phosphorylation/oxidation cou-
pling of interfibrillar mitochondria with all substrates tested
(Fig. 1), which may explain why cardiac oxygen con-
sumption in high fat-fed isolated hearts was increased
irrespective of perfusion substrate. In isolated high fat-fed
rat cardiac mitochondria, inhibition of UCP3 increased
phosphorylation efficiency to control levels. Cardiac levels
of UCP3 are elevated in severe rodent models of type 2
diabetes [31], type 1 diabetes [31], hyperthyroidism [3] and
heart failure [30], all of which are characterised by elevated
plasma FFA levels. However, increased cardiac UCP3
levels in disease models have not always been found [4, 9,
10], despite increased proton leak in isolated cardiac
mitochondria [4, 22]. Here, we found that diet-induced
elevation of plasma FFAs was sufficient to elevate cardiac
levels of both UCP3 and MTE-1 by 20%. UCP3 and MTE-
1 are upregulated in heart via activation of PPARa [18, 45],
and it has been suggested that the two proteins might act in
concert to export fatty acid anions from the mitochondrial
matrix as a protective mechanism [21] or to increase fatty
acid oxidation [45]. High fat feeding did not, however,
alter cardiac levels of ANT, another putative mitochon-
drial uncoupler of rat heart mitochondria [7, 40], or the
a-subunit of the F0F1 ATP synthase. Therefore, mito-
chondrial uncoupling, not increased numbers of mito-
chondria, may explain the increased oxygen consumption
and decreased efficiency of the high fat-fed rat heart.
A positive consequence of an increase in UCP3 protein
and uncoupling of mitochondrial respiration may be that
cardiac ROS production from the electron transport chain
is reduced [6, 14] as the electrochemical gradient driving
the electron transport chain becomes dissipated. Several
studies report reduced ROS production with an increase in
UCP3 protein [13, 47], a relationship supported by the
reverse observation, in that decreased cardiac UCP3 pro-
tein is accompanied by increased ROS production [8]. We
found no evidence of mitochondrial oxidative protein
modification with high fat feeding, indicating that ROS-
mediated damage was unaltered. More prolonged high fat
feeding may be required to produce oxidative protein
modification; others have shown that although total myo-
cardial protein carbonylation was unaltered after 4 weeks,
it had increased after 16 weeks of feeding a 60% fat diet
[51]. Thus, the duration of high fat feeding was probably
insufficient for the increased UCP3 proteins to have a
measureable effect on ROS generation and oxidative pro-
tein modification.
Conclusion
In conclusion, we have demonstrated that high fat diet-
induced obesity, in the absence of overt diabetes, increased
mitochondrial UCP3 levels and the capacity for fatty acid
oxidation in cardiac mitochondria, resulting in mitochon-
drial uncoupling. In the absence of changes in cardiac
function, oxygen consumption increased, thereby decreas-
ing cardiac efficiency. Thus, mitochondrial uncoupling
may underlie the cardiac energetic abnormalities observed
in diabetic patients prior to the development of functional
impairment [39].
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